Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Sector Investor who wrote (956)	6/12/2000 11:18:00 AM
From: david james	Read Replies (1) \| Respond to of 1298

Looks like we had a stop run. Lets see if they bring it back up towards the close. Great timing for the CEO with the TKTX trial getting lots of attention and gene therapy making a comeback. So Sherwin will be on CNBC then follow that with his presentation to the Goldman Sachs conference. Cell Genesys deserves some new analyst coverage. Maybe this will help my.tveyes.com Tommorrow, guest host mighty jack rivkin, and the ceo of cell genesys I'm mark haines. Let's keep it going now by handing it over for the start of "market watch."

To: Sector Investor who wrote (956)	6/13/2000 12:32:00 AM
From: allen menglin chen	Respond to of 1298

CNBC Squawk Box: 7:00-10:00AM ET Jack Rivkin Executive VP Citigroup Investments Squawk Guest Host Roberta Goodman Analyst Merrill Lynch re: Sector Spotlight Brian Fabbri Chief Economist BNP Paribas re: Econ-O-Rama Constance Mitchell Ford Economics Editor The Wall Street Journal re: Econ-O-Rama Jack Bouroudjian Senior VP of Equity Commerz Futures re: Econ-O-Rama Stephen Sherwin Chairman and CEO Cell Genesys {CEGE} re: CEO Call Gregory Reyes CEO Brocade Communications {BRCD} re: CEO Call